We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.


Biomarker-based Companion Diagnostics Are Enabling Precision Oncology

Clinical trials are underway to examine the efficacy of various immune checkpoint inhibitor molecules, for the treatment of cancer.

Watch this video to learn about the companion diagnostics that are enabling the identification of patients who could benefit from these treatments.